相关实验视频
Updated: Jan 22, 2026

06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
34.9K
心脏衰竭中的细胞衰老:一篇评论
Kamil Krauz1, Katarzyna Czarzasta1, Mikołaj Bugajewski1
1Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Journal of cellular physiology
|January 21, 2026
概括
细胞衰老有助于心力衰竭 (HF) 的发展和进展. 向衰老细胞和相关的血蛋白质提供了改善HF结果的潜在治疗策略.
科学领域:
- 心脏病学 心脏病学
- 老年学是一门学科.
- 细胞生物学 细胞生物学
背景情况:
- 心力衰竭 (HF) 是一个日益严重的全球健康问题,治疗选择有限.
- 衰老是HF的主要风险因素,细胞衰老越来越多地与其病变有关.
- 细胞衰老在HF中的确切作用是复杂的,并取决于细胞类型.
研究的目的:
- 审查细胞衰老和心力衰竭之间的复杂关系.
- 探索血中衰老细胞标记物的潜力,作为HF的生物标记物和预后指标.
- 总结当前和新兴的老化向治疗方法对HF.
主要方法:
- 关于细胞衰老和心力衰竭研究的综合文献综述.
- 对HF患者与细胞衰老相关的血蛋白研究的分析.
- 在高频率的背景下,针对细胞衰老的治疗策略的评估.
主要成果:
- 细胞衰老,一种不可逆转的细胞循环停止状态,是HF病变发生的重要因素.
- 与衰老相关的等离子体蛋白显示出具有前途的生物标志物和HF的预后因素.
- 向衰老细胞为HF治疗提供了潜在的治疗途径.
结论:
- 细胞衰老在心力衰竭的发展和进展中起着多方面的作用.
- 对与衰老相关的血蛋白质的进一步研究可以完善HF诊断和预后.
- 抗衰老药物和其他针对衰老的疗法需要对高温热管理进行研究.
相关概念视频
Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227

